红日药业(300026.SZ)多位股东拟合计减持不超1.58%股份

Core Viewpoint - The company Hongri Pharmaceutical (300026.SZ) has announced a share reduction plan involving significant shareholders and senior management [1] Shareholder Reduction Plans - Shareholder Yao Xiaoqing plans to reduce holdings by up to 46.9363 million shares, representing 1.5624% of the total share capital through centralized bidding or block trading [1] - Senior management member Chen Ruiqiang intends to reduce holdings by up to 169,000 shares, accounting for 0.0056% of the total share capital through centralized bidding [1] - Senior management member Zhang Kun plans to reduce holdings by up to 232,000 shares, which is 0.0077% of the total share capital, also through centralized bidding [1]